ReviewJournal of thoracic disease2021

The role of long-acting muscarinic antagonist/long-acting β agonist fixed-dose combination treatment for chronic obstructive pulmonary disease in China: a narrative review.

Ji'an Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.